Same Indication

Nivolumab vs Spironolactone

Nivolumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between Nivolumab and Spironolactone.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Spironolactone: Mineralocorticoid receptor antagonist.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Spironolactone — 1.4 hours.

Chemical Properties

Molecular Formula: Spironolactone — C24H32O4S.

Molecular Weight: Spironolactone — 416.5740 g/mol.

Type: Nivolumab — Antibody; Spironolactone — Small molecule.